Position in ALNY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$37,719
-$5,624 QoQ
Shares Held
114
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SHP Wealth Management holds $639,878 across 41 Biotechnology names. ALNY ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
524 | $233,986 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,001 | $169,189 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,976 | $79,652 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
50 | $38,632 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
114 | $37,719 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
42 | $12,472 | |
| 7 | BNTX |
BioNTech SE
|
110 | $9,776 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
2,000 | $8,580 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,719 | 114 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $43,343 | 109 | Shares | Sole | 2026-03-04 | |
| No filing history on record for this holder in this stock. | ||||||